Stellar Biotechnologies, Inc. (41) | Business Finance (16)
Browse by Subcategory
Recent Contracts
-
Form of Pre-Funded Warrant
(Filed With SEC on March 23, 2022)
-
Form of Securities Purchase Agreement, dated March 21, 2022, by and between the Company and the Purchaser
(Filed With SEC on March 23, 2022)
-
First Amendment to Equity Distribution Agreement, dated as of March 4, 2022, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC
(Filed With SEC on March 4, 2022)
-
Underwriting Agreement
(Filed With SEC on February 26, 2021)
-
Form of Subscription Agreement between Edesa Biotech, Inc. and certain investors
(Filed With SEC on January 6, 2020)
-
Share Exchange Agreement, dated as of March 7, 2019, by and between Stellar Biotechnologies Inc., Edesa Biotech Inc. and the Edesa Shareholders
(Filed With SEC on March 8, 2019)
-
Form of Private Placement Warrant
(Filed With SEC on March 23, 2022)
-
Form of Placement Agent Warrant
(Filed With SEC on March 23, 2022)
-
Equity Distribution Agreement, dated as of November 22, 2021, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC
(Filed With SEC on November 22, 2021)
-
Form of Underwriter Warrant
(Filed With SEC on February 26, 2021)
-
Equity Distribution Agreement, dated as of September 28, 2020, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC
(Filed With SEC on September 28, 2020)
-
Securities Purchase Agreement by and between Edesa Biotech, Inc. and NovImmune SA dated April 17, 2020
(Filed With SEC on April 23, 2020)
-
Purchase Agreement by and between Edesa Biotech Research, Inc. and NovImmune SA dated April 17, 2020
(Filed With SEC on April 23, 2020)
-
Form of Class A Purchase Warrant to be issued to investors
(Filed With SEC on January 6, 2020)
-
Form of Class B Purchase Warrant to be issued to investors
(Filed With SEC on January 6, 2020)
-
Form of Warrant to be issued to Brookline Capital Markets, a division of Arcadia Securities, LLC
(Filed With SEC on January 6, 2020)